Pascal Biosciences Inc (8DZ) Financial Statements
Pascal Biosciences Inc Financial Overview
Pascal Biosciences Inc's market cap is currently $506.82K. The company's EPS TTM is $-0.01; its P/E ratio is -3.22; Pascal Biosciences Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Nov 25 | Feb 25 | Feb 24 | Nov 22 | Feb 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.70M | $ 1.55M | $ 671.54K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 396.31K | $ 1.08M | $ 392.94K | $ -8.29K | $ -16.32K |
| Operating Income | $ -290.45K | $ -220.15K | $ -868.13K | $ -556.88K | $ -1.08M |
| EBITDA | $ -32.66K | $ -48.07K | $ -271.56K | $ -468.09K | $ -1.07M |
| Net Income | $ -275.07K | $ -362.48K | $ -399.77K | $ -480.28K | $ -1.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 102.17K | $ 129.54K | $ 418.52K | $ 8.37K | $ 0.00 |
| Total Assets | $ 1.72M | $ 2.04M | $ 2.50M | $ 18.82K | $ 155.19K |
| Total Debt | $ 244.21K | $ 528.30K | $ 683.27K | $ 224.62K | $ 7.76K |
| Net Debt | $ 142.04K | $ 398.76K | $ 264.75K | $ 216.25K | $ 7.76K |
| Total Liabilities | $ 746.36K | $ 813.50K | $ 1.12M | $ 962.93K | $ 646.48K |
| Stockholders' Equity | $ 968.95K | $ 1.23M | $ 1.38M | $ -944.11K | $ -491.30K |
| Cash Flow | |||||
| Free Cash Flow | $ 62.10K | $ -132.06K | $ -390.49K | $ -147.68K | $ -614.93K |
| Operating Cash Flow | $ 62.10K | $ -120.50K | $ -385.35K | $ -147.68K | $ -614.93K |
| Investing Cash Flow | $ 0.00 | $ -11.56K | $ -947.71K | $ 8.98K | $ 0.00 |
| Financing Cash Flow | $ -90.20K | $ -167.65K | $ 1.76M | $ 154.84K | $ 624.08K |
Currency in CAD
